Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minakem
Beuvry-la-forêt, Hauts-de-France, Franceminakem.com ↗
- Ownership
- Private
- Employees
- ~394
- Development stage
- Other
01
Overview
Minakem does not have its own clinical pipeline or results. It provides cGMP manufacturing and development services for small molecule APIs—including highly potent compounds—for global pharmaceutical clients at all stages from preclinical to commercial supply. The company’s expertise includes complex multi-step synthesis, chiral chemistry, steroid chemistry, halogenation chemistry, pressure chemistry and more. Facilities are FDA-inspected and support both innovators’ and generics’ products. Recent expansions include high-potency API capabilities in Belgium and North America.
- Modalities
- Small moleculeSteroidHighly potent active pharmaceutical ingredient (HPAPI)Fine chemicalsIntermediates
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Minakem.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Minakem.